ATE354639T1 - Virulenz gene, proteine, und ihre verwendung - Google Patents

Virulenz gene, proteine, und ihre verwendung

Info

Publication number
ATE354639T1
ATE354639T1 AT01931888T AT01931888T ATE354639T1 AT E354639 T1 ATE354639 T1 AT E354639T1 AT 01931888 T AT01931888 T AT 01931888T AT 01931888 T AT01931888 T AT 01931888T AT E354639 T1 ATE354639 T1 AT E354639T1
Authority
AT
Austria
Prior art keywords
genes
microorganisms
proteins
virulence genes
dna
Prior art date
Application number
AT01931888T
Other languages
English (en)
Inventor
Christoph Tang
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microscience Ltd filed Critical Microscience Ltd
Application granted granted Critical
Publication of ATE354639T1 publication Critical patent/ATE354639T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01931888T 2000-05-18 2001-05-18 Virulenz gene, proteine, und ihre verwendung ATE354639T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012079.0A GB0012079D0 (en) 2000-05-18 2000-05-18 Virulence gene and protein, and their use

Publications (1)

Publication Number Publication Date
ATE354639T1 true ATE354639T1 (de) 2007-03-15

Family

ID=9891892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931888T ATE354639T1 (de) 2000-05-18 2001-05-18 Virulenz gene, proteine, und ihre verwendung

Country Status (8)

Country Link
US (1) US20030170261A1 (de)
EP (2) EP1803807A3 (de)
AT (1) ATE354639T1 (de)
AU (1) AU2001258579A1 (de)
DE (1) DE60126765T2 (de)
ES (1) ES2282254T3 (de)
GB (1) GB0012079D0 (de)
WO (1) WO2001087939A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0308691D0 (en) * 2003-04-07 2003-05-21 Xenova Res Ltd Vaccine preparations
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425853A1 (de) 2005-04-08 2012-03-07 Wyeth LLC Multivalente Pneumokokken-Polysaccharidproteinkonjugatzusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
MXPA01003557A (es) * 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
NZ527279A (en) * 1998-11-09 2005-05-27 Microscience Ltd Virulence genes and proteins, and their use
AU783894B2 (en) * 1999-05-19 2005-12-22 Novartis Vaccines And Diagnostics S.R.L. Combination neisserial compositions

Also Published As

Publication number Publication date
US20030170261A1 (en) 2003-09-11
ES2282254T3 (es) 2007-10-16
DE60126765D1 (de) 2007-04-05
EP1803807A2 (de) 2007-07-04
EP1803807A3 (de) 2007-09-05
WO2001087939A2 (en) 2001-11-22
DE60126765T2 (de) 2007-11-15
AU2001258579A1 (en) 2001-11-26
EP1290137B1 (de) 2007-02-21
EP1290137A2 (de) 2003-03-12
WO2001087939A3 (en) 2002-03-28
GB0012079D0 (en) 2000-07-12

Similar Documents

Publication Publication Date Title
ATE382056T1 (de) Virulenz gene, proteine, und ihre verwendung
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
IL146937A (en) Method for producing a progeny library comprised of polynucleotide sequences
DK1741784T3 (da) 85kDa-antigen fra neisseria
ATE527276T1 (de) Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung
ATE338820T1 (de) Proteine von bacillus thuringiensis und varianten davon mit pestizider wirkung gegen coleoptera
ATE427114T1 (de) Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen
DE50211324D1 (de) Verfahren zur herstellung von polyurethanelastomeren und verwendung
ATE384797T1 (de) Streptococcus pyogenes virulenz gene und proteine und ihre verwendungen
WO2005058945A3 (de) Genvarianten die für proteine aus dem stoffwechselweg von feinchemikalien kodieren
DE60126765D1 (de) Virulenz gene, proteine, und ihre verwendung
FR2793257B1 (fr) Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
NO20013102D0 (no) Gener, proteiner og deres anvendelse
ATE383425T1 (de) Virulenzgene und deren proteine und verwendungen
ATE466086T1 (de) Expec-spezifische proteine, entsprechende gene und ihre verwendungen
WO2003000930A3 (en) Nucleotide sequences involved in plant disease resistance
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
MXPA02010337A (es) Mutantes de bacterias lacticas que sobreproducen exopolisacaridos.
WO2002016612A3 (en) Genes and proteins, and their uses
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
DE50107566D1 (de) Nukleotidsequenzen kodierend fur proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veranderter mikroorganismus
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
WO2004057018A3 (en) Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use
DE60125507D1 (de) Nukleinsäuren und Proteine des mph3 Gens aus Mycoplasma hypopneumoniae und deren Verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties